PharmaEssentia Corporation (6446.TW)

TWD 530.0

(-1.49%)

Net Income Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual net income in 2023 was -623.83 Million TWD , up 54.62% from previous year.
  • PharmaEssentia Corporation's latest quarterly net income in 2024 Q2 was 679.82 Million TWD , up 105.77% from previous quarter.
  • PharmaEssentia Corporation reported an annual net income of -1.37 Billion TWD in 2022, up 51.09% from previous year.
  • PharmaEssentia Corporation reported an annual net income of -2.81 Billion TWD in 2021, down -44.29% from previous year.
  • PharmaEssentia Corporation reported a quarterly net income of 679.82 Million TWD for 2024 Q2, up 105.77% from previous quarter.
  • PharmaEssentia Corporation reported a quarterly net income of -202.75 Million TWD for 2023 Q2, up 72.43% from previous quarter.

Annual Net Income Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Net Income of PharmaEssentia Corporation (2023 - 2019)

Year Net Income Net Income Growth
2023 -623.83 Million TWD 54.62%
2022 -1.37 Billion TWD 51.09%
2021 -2.81 Billion TWD -44.29%
2020 -1.94 Billion TWD -131.1%
2019 -842.99 Million TWD 0.0%

Peer Net Income Comparison of PharmaEssentia Corporation

Name Net Income Net Income Difference
Grape King Bio Ltd 1.45 Billion TWD 142.942%
Standard Chem & Pharm CO., LTD. 834.88 Million TWD 174.721%
Maywufa Company Ltd. 169.09 Million TWD 468.919%
ScinoPharm Taiwan, Ltd. 287.05 Million TWD 317.322%
Lotus Pharmaceutical Co., Ltd. 4.1 Billion TWD 115.195%
LIWANLI Innovation Co., Ltd. 5.1 Million TWD 12324.868%
YungShin Global Holding Corporation 827.3 Million TWD 175.406%
PhytoHealth Corporation -47.11 Million TWD -1224.013%
SCI Pharmtech, Inc. 294.72 Million TWD 311.67%
Formosa Laboratories, Inc. 126.24 Million TWD 594.154%
Bora Pharmaceuticals Co., LTD. 3.03 Billion TWD 120.588%